Skip to content

Clinical trials

Completed Liver Cirrhosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Status: Completed Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20061
20092
20112
20131
20152
20161
20171
20182
20191
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Arbor Research Collaborative for Health2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
University of Alberta2
AstraZeneca1
Atea Pharmaceuticals, Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Echosens1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis24
Ascites6
Hepatitis C4
Non-alcoholic Fatty Liver Disease4
Fatty Liver3
Fibrosis3
Liver Diseases3
Alagille Syndrome1
Anxiety Disorders1
Biliary Atresia1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.